Anabolic and anticatabolic agents in critical care

Mile Stanojcic, Celeste Finnerty, Marc G. Jeschke

Research output: Contribution to journalReview article

14 Scopus citations

Abstract

Profound metabolic derangements occur in critically ill patients; this hypermetabolic response is a major contributor to adverse outcomes. Despite the pharmacological therapies currently available to counteract this devastating cascade, future studies are warranted to explore new multimodality agents that will counteract these effects while maintaining glycemic control and preventing unfavorable complications.

Original languageEnglish (US)
Pages (from-to)325-331
Number of pages7
JournalCurrent Opinion in Critical Care
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2016

    Fingerprint

Keywords

  • anabolic
  • anticatabolic
  • burns
  • critical illness
  • hypermetabolism
  • insulin
  • metformin
  • oxandrolone
  • propranolol

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this